Adverse glucocorticoid actions and their relevance to brain ageing

NeuroImmune Biology

Volumn 4, Issue C, 2004, Pages 331-346

  Dinkel, Klaus ^a   Sapolsky, Robert M ^b  

^a LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957095634     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(04)80022-X     Document Type: Chapter

References (127)

1. Lupien S.J., de Leon M., de Santi S., Convit A., Tarshish C., Nair N.P., et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1 1 (1998) 69-73
2. Straub R.H., Miller L.E., Scholmerich J., and Zietz B. Cytokines and hormones as possible links between endocrinosenescence and immunosenescence. J Neuroimmunol 109 1 (2000) 10-15
3. Reul J.M., and de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occuptation. Endocrinology 117 6 (1985) 2505-2511
4. Siesjo B. Cellular and Molecular Mechanisms of Ischemic Brain Damage (1996), Lippincott-Raven, NY
5. Lee J.M., Zipfel G.J., and Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature 399 6738 Suppl (1999) A7-A14
6. Perez-Pinzon M.A., Sick T.J., and Rosenthal M. Mechanism(s) of mitochondrial hyperoxidation after global cerebral ischemia. Adv Exp Med Biol 471 (1999) 175-180
7. Sattler R., and Tymianski M. Molecular mechanisms of calcium-dependent excitotoxicity. J Mol Med 78 1 (2000) 3-13
8. Choi D.W. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 6 5 (1996) 667-672
9. Roy M., and Sapolsky R. Neuronal apoptosis in acute necrotic insults: why is this subject such a mess?. Trends Neurosci 22 10 (1999) 419-422
10. Sapolsky R.M. A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. J Neurosci 5 5 (1985) 1228-1232
11. Sapolsky R.M. Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels. J Neurosci 6 8 (1986) 2240-2244
12. Sapolsky R.M. Glucocorticoid toxicity in the hippocampus. Temporal aspects of synergy with kainic acid. Neuroendocrinology 43 3 (1986) 440-444
13. Stein-Behrens B., Mattson M.P., Chang I., Yeh M., and Sapolsky R. Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus. J Neurosci 14 9 (1994) 5373-5380
14. Supko D.E., and Johnston M.V. Dexamethasone potentiates NMDA receptor-mediated neuronal injury in the postnatal rat. Eur J Pharmacol 270 1 (1994) 105-113
15. Smith-Swintosky V.L., Pettigrew L.C., Sapolsky R.M., Phares C., Craddock S.D., Brooke S.M., et al. Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures. J Cereb Blood Flow Metab 16 4 (1996) 585-598
16. Sapolsky R.M., and Pulsinelli W.A. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 229 4720 (1985) 1397-1400
17. Koide T., Wieloch T.W., and Siesjo B.K. Chronic dexamethasone pretreatment aggravates ischemic neuronal necrosis. J Cereb Blood Flow Metab 6 4 (1986) 395-404
18. Morse J.K., and Davis J.N. Regulation of ischemic hippocampal damage in the gerbil: adrenalectomy alters the rate of CA1 cell disappearance. Exp Neurol 110 1 (1990) 86-92
19. Tuor U.I., Chumas P.D., and Del Bigio M.R. Prevention of hypoxic-ischemic damage with dexamethasone is dependent on age and not influenced by fasting. Exp Neurol 132 1 (1995) 116-122
20. Amoroso D., Kindel G., Wulfert E., and Hanin I. Long-term exposure to high levels of corticosterone aggravates AF64A-induced cholinergic hypofunction in rat hippocampus in vivo. Brain Res 661 1-2 (1994) 9-18
21. Hortnagl H., Berger M.L., Havelec L., and Hornykiewicz O. Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A). J Neurosci 13 7 (1993) 2939-2945
22. Johnson M., Stone D.M., Bush L.G., Hanson G.R., and Gibb J.W. Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity. Eur J Pharmacol 161 2-3 (1989) 181-188
23. Stein B.A., and Sapolsky R.M. Chemical adrenalectomy reduces hippocampal damage induced by kainic acid. Brain Res 473 1 (1988) 175-180
24. Sapolsky R.M., Packan D.R., and Vale W.W. Glucocorticoid toxicity in the hippocampus: in vitro demonstration. Brain Res 453 1-2 (1988) 367-371
25. Packan D.R., and Sapolsky R.M. Glucocorticoid endangerment of the hippocampus: tissue, steroid and receptor specificity. Neuroendocrinology 51 6 (1990) 613-618
26. Goodman Y., AJ B., Cheng B., and Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 66 5 (1996) 1836-1844
27. Rajan V., Edwards C.R., and Seckl J.R. 11 beta-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J Neurosci 16 1 (1996) 65-70
28. Tombaugh G.C., Yang S.H., Swanson R.A., and Sapolsky R.M. Glucocorticoids exacerbate hypoxic and hypoglycemic hippocampal injury in vitro: biochemical correlates and a role for astrocytes. J Neurochem 59 1 (1992) 137-146
29. Chou Y.C. Corticosterone exacerbates cyanide-induced cell death in hippocampal cultures: role of astrocytes. Neurochem Int 32 3 (1998) 219-226
30. McIntosh L.J., and Sapolsky R.M. Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture. Exp Neurol 141 2 (1996) 201-206
31. Limoges J., Persidsky Y., Bock P., and Gendelman H.E. Dexamethasone therapy worsens the neuropathology of human immunodeficiency virus type 1 encephalitis in SCID mice. J Infect Dis 175 6 (1997) 1368-1381
32. Brooke S., Chan R., Howard S., and Sapolsky R. Endocrine modulation of the neurotoxicity of gp 120: implications for AIDS-related dementia complex. Proc Natl Acad Sci U S A 94 17 (1997) 9457-9462
33. Brooke S.M., Howard S.A., and Sapolsky R.M. Energy dependency of glucocorticoid exacerbation of gp 120 neurotoxicity. J Neurochem 71 3 (1998) 1187-1193
34. Howard S.A., Nakayama A.Y., Brooke S.M., and Sapolsky R.M. Glucocorticoid modulation of gp120-induced effects on calcium-dependent degenerative events in primary hippocampal and cortical cultures. Exp Neurol 158 1 (1999) 164-170
35. Yusim A., Franklin L., Brooke S., Ajilore O., and Sapolsky R. Glucocorticoids exacerbate the deleterious effects of gp120 in hippocampal and cortical explants. J Neurochem 74 3 (2000) 1000-1007
36. Iyer A.M., Brooke S.M., and Sapolsky R.M. Glucocorticoids interact with gp120 in causing neurotoxicity in striatal cultures. Brain Res 808 2 (1998) 305-309
37. discussion 127-8. Uhler T.A., Frim D.M., Pakzaban P., and Isacson O. The effects of megadose methylprednisolone and U-78517F on toxicity mediated by glutamate receptors in the rat neostriatum. Neurosurgery 34 1 (1994) 122-127
38. Abraham I., Veenema A.H., Nyakas C., Harkany T., Bohus B.G., and Luiten P.G. Effect of corticosterone and adrenalectomy on NMDA-induced cholinergic cell death in rat magnocellular nucleus basalis. J Neuroendocrinol 9 9 (1997) 713-720
39. Abraham I., Harkany T., Horvath K.M., Veenema A.H., Penke B., Nyakas C., et al. Chronic corticosterone administration dose-dependently modulates Abeta(1-42)- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis. J Neuroendocrinol 12 6 (2000) 486-494
40. Sunanda, Rao B.S., and Raju T.R. Corticosterone attenuates zinc-induced neurotoxicity in primary hippocampal cultures. Brain Res 791 1-2 (1998) 295-298
41. Barks J.D., Post M., and Tuor U.I. Dexamethasone prevents hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res 29 6 (1991) 558-563
42. Tuor U.I., Simone C.S., Arellano R., Tanswell K., and Post M. Glucocorticoid prevent of neonatal hypoxic-ischemic damage: role of hyperglycemia and antioxidant enzymes. Brain Res 604 1-2 (1993) 165-172
43. Tuor U.I., Simone C.S., Barks J.D., and Post M. Dexamethasone prevents cerebral infarction without affecting cerebral blood flow in neonatal rats. Stroke 24 3 (1993) 452-457
44. Chumas P.D., Del Bigio M.R., Drake J.M., and Tuor U.I. A comparison of the protective effect of dexamethasone to other potential prophylactic agents in a neonatal rat model of cerebral hypoxia-ischemia. J Neurosurg 79 3 (1993) 414-420
45. Bracken M.B., Shepard M.J., Collins W.F., Holford T.R., Young W., Baskin D.S., et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 322 20 (1990) 1405-1411
46. Braughler J.M., and Hall E.D. Current application of "high-dose" steroid therapy for CNS injury. A pharmacological perspective. J Neurosurg 62 6 (1985) 806-810
47. Young W., and Flamm E.S. Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury. J Neurosurg 57 5 (1982) 667-673
48. Sapolsky R.M. Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Exp Gerontol 34 6 (1999) 721-732
49. Kadekaro M., Ito M., and Gross P.M. Local cerebral glucose utilization is increased in acutely adrenalectomized rats. Neuroendocrinology 47 4 (1988) 329-334
50. Doyle P., Rohner-Jeanrenaud F., and Jeanrenaud B. Local cerebral glucose utilization in brains of lean and genetically obese (fa/fa) rats. Am J Physiol 264 1 Pt 1 (1993) E29-E36
51. Doyle P., Rohner-Jeanrenaud F., and Jeanrenaud B. Alterations of local cerebral glucose utilization in lean and obese fa/fa rats after acute adrenalectomy. Brain Res 655 1-2 (1994) 115-120
52. Freo U., Holloway H.W., Kalogeras K., Rapoport S.I., and Soncrant T.T. Adrenalectomy or metyrapone-pretreatment abolishes cerebral metabolic responses to the serotonin agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the hippocampus. Brain Res 586 2 (1992) 256-264
53. Horner H.C., Packan D.R., and Sapolsky R.M. Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 52 1 (1990) 57-64
54. Virgin Jr. C.E., Ha T.P., Packan D.R., Tombaugh G.C., Yang S.H., Horner H.C., et al. Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. J Neurochem 57 4 (1991) 1422-1428
55. Tombaugh G.C., and Sapolsky R.M. Corticosterone accelerates hypoxia- and cyanide-induced ATP loss in cultured hippocampal astrocytes. Brain Res 588 1 (1992) 154-158
56. Lawrence M.S., and Sapolsky R.M. Glucocorticoids accelerate ATP loss following metabolic insults in cultured hippocampal neurons. Brain Res 646 2 (1994) 303-306
57. Chou Y.C., Lin W.J., and Sapolsky R.M. Glucocorticoids increase extracellular [3H]D-aspartate overflow in hippocampal cultures during cyanide-induced ischemia. Brain Res 654 1 (1994) 8-14
58. Stein-Behrens B.A., Elliott E.M., Miller C.A., Schilling J.W., Newcombe R., and Sapolsky R.M. Glucocorticoids exacerbate kainic acid-induced extracellular accumulation of excitatory amino acids in the rat hippocampus. J Neurochem 58 5 (1992) 1730-1735
59. Lowy M.T., Wittenberg L., and Yamamoto B.K. Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats. J Neurochem 65 1 (1995) 268-274
60. Elliott E.M., and Sapolsky R.M. Corticosterone enhances kainic acid-induced calcium elevation in cultured hippocampal neurons. J Neurochem 59 3 (1992) 1033-1040
61. Elliott E.M., Mattson M.P., Vanderklish P., Lynch G., Chang I., and Sapolsky R.M. Corticosterone exacerbates kainates-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo. J. Neurochem 61 1 (1993) 57-67
62. Sattler R., Charlton M.P., Hafner M., and Tymianski M. Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J Neurochem 71 6 (1998) 2349-2364
63. Elliott E.M., and Sapolsky R.M. Corticosterone impairs hippocampal neuronal calcium regulation--possible mediating mechanisms. Brain Res 602 1 (1993) 84-90
64. McIntosh L.J., Hong K.E., and Sapolsky R.M. Glucocorticoids may alter antioxidant enzyme capacity in the brain: baseline studies. Brain Res 791 1-2 (1998) 209-214
65. Brooke S.M., and Sapolsky R.M. The effects of steroid hormones in HIV-related neurotoxicity: a mini review. Biol Psychiatry 48 9 (2000) 881-893
66. Brooke S.M., McLaughlin J.R., Cortopassi K.M., and Sapolsky R.M. Effect of GP120 on glutathione peroxidase activity in cortical cultures and the interaction with steroid hormones. J Neurochem 81 2 (2002) 277-284
67. Patel R., McIntosh L., McLaughlin J., Brooke S., Nimon V., and Sapolsky R. Disruptive effects of glucocorticoids on glutathione peroxidase biochemistry in hippocampal cultures. J Neurochem 82 1 (2002) 118-125
68. Abraham I., Juhasz G., Kekesi K.A., and Kovacs K.J. Corticosterone peak is responsible for stress-induced elevation of glutamate in the hippocampus. Stress 2 3 (1998) 171-181
69. Venero C., and Borrell J. Rapid glucocorticoid effects on excitatory amino acid levels in the hippocampus: a microdialysis study in freely moving rats. Eur J Neurosci 11 7 (1999) 2465-2473
70. Cato A.C., and Wade E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 18 5 (1996) 371-378
71. Marx J. How the glucocorticoids suppress immunity. Science 270 5234 (1995) 232-233
72. Kern J.A., Lamb R.J., Reed J.C., Daniele R.P., and Nowell P.C. Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest 81 1 (1988) 237-244
73. Goulding N.J., Euzger H.S., Butt S.K., and Perretti M. Novel pathways for glucocorticoid effects on neutrophils in chronic inflammation. Inflamm Res 47 Suppl 3 (1998) S158-S165
74. Perretti M., and Flower R.J. Cytokines, glucocorticoids and lipocortins in the control of neutrophil migration. Pharmacol Res 30 1 (1994) 53-59
75. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332 20 (1995) 1351-1362
76. Reagan L.P., and McEwen B.S. Controveries surrounding glucocorticoid-mediated cell death in the hippocampus. J Chem Neuroanat 13 3 (1997) 149-167
77. Hench P.K., Slocumb C.H., and Polley H.F. The effects of a hormone of the adrenal cortex and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Mayo Clin 24 (1949) 181-197
78. Lloberas J., and Celada A. Effect of aging on macrophage function. Exp Gerontol 37 12 (2002) 1325-1331
79. Cronstein B.N., Kimmel S.C., Levin R.I., Martiniuk F., and Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 89 21 (1992) 9991-9995
80. Getting S.J., Flower R.J., and Perretti M. Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1. Br J Pharmacol 120 6 (1997) 1075-1082
81. Gavazzi G., and Krause K.H. Ageing and infection. Lancet Infect Dis 2 11 (2002) 659-666
82. Gardner E.M., and Murasko D.M. Age-related changes in Type 1 and Type 2 cytokine production in humans. Biogerontology 3 5 (2002) 271-290
83. Kiecolt-Glaser J.K., Dura J.R., Speicher C.E., Trask O.J., and Glaser R. Spousal caregivers of dementia victims: longitudinal changes in immunity and health. Psychosom Med 53 4 (1991) 345-362
84. Castle S., Wilkins S., Heck E., Tanzy K., and Fahey J. Depression in caregivers of demented patients is associated with altered immunity: impaired proliferative capacity, increased CD8+, and a decline in lymphocytes with surface signal transduction molecules (CD38+) and a cytotoxicity marker (CD56+ CD8+). Clin Exp Immunol 101 3 (1995) 487-493
85. Vedhara K., Cox N.K., Wilcock G.K., Perks P., Hunt M., Anderson S., et al. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 353 9153 (1999) 627-631
86. Bauer M.E., Vedhara K., Perks P., Wilcock G.K., Lightman S.L., and Shanks N. Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids. J Neuroimmunol 103 1 (2000) 84-92
87. Rohleder N., Kudielka B.M., Hellhammer D.H., Wolf J.M., and Kirschbaum C. Age and sex steroid-related changes in glucocorticoid sensitivity of pro-inflammatory cytokine production after psychosocial stress. J Neuroimmunol 126 1-2 (2002) 69-77
88. Bruccoleri A., Pennypacker K.R., and Harry G.J. Effect of dexamethasone on elevated cytokine mRNA levels in chemical-induced hippocampal injury. J Neurosci Res 57 6 (1999) 916-926
89. Millikan C.H.M.F., and Easton J.D. Progressing stroke (1987), Lea&Febiger, Philadelphia, PA
90. Asanuma M., Nishibayashi-Asanuma S., Miyazaki I., Kohno M., and Ogawa N. Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J Neurochem 76 6 (2001) 1895-1904
91. Breitner J.C. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu Rev Med 47 (1996) 401-411
92. Fishman R.A. Steroids in the treatment of brain edema. N Engl J Med 306 6 (1982) 359-360
93. Tominaga T., Katagi H., and Ohnishi S.T. Is Ca2+ -activated potassium efflux involved in the formation of ischemic brain edema?. Brain Res 460 2 (1988) 376-378
94. Aisen P.S., Davis K.L., Berg J.D., Schafer K., Campbell K., Thomas R.G., et al. A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology 54 3 (2000) 588-593
95. Uz T., Dwivedi Y., Savani P.D., Impagnatiello F., Pandey G., and Manev H. Glucocorticoids stimulate inflammatory 5-lipoxygenase gene expression and protein translocation in the brain. J Neurochem 73 2 (1999) 693-699
96. Uz T., Pesold C., Longone P., and Manev H. Aging-associated up-regulation of neuronal 5-lipoxygenase expression: putative role in neuronal vulnerability. Faseb J 12 6 (1998) 439-449
97. Padgett D.A., MacCallum R.C., and Sheridan J.F. Stress exacerbates age-related decrements in the immune response to an experimental influenza viral infection. J Gerontol A Biol Sci Med Sci 53 5 (1998) B347-B353
98. Tenser R.B., and Hsiung G.D. Pathogenesis of latent herpes simplex virus infection of the trigeminal ganglion in guinea pigs: effects of age, passive immunization, and hydrocortisone. Infect Immun 16 1 (1977) 69-74
99. Labrada L., Liang X.H., Zheng W., Johnston C., and Levine B. Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12. J Virol 76 22 (2002) 11688-11703
100. Terrazzino S., Perego C., De Luigi A., and De Simoni M.G. Interleukin-6, tumor necrosis factor and corticosterone induction by central lipopolysaccharide in aged rats. Life Sci 61 7 (1997) 695-701
101. Goss J.R., Finch C.E., and Morgan D.G. Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain. Neurobiol Aging 12 2 (1991) 165-170
102. Morgan T.E., Rozovsky I., Goldsmith S.K., Stone D.J., Yoshida T., and Finch C.E. Increased transcription of the astrocyte gene GFAP during middle-age is attenuated by food restriction: implications for the role of oxidative stress. Free Radic Biol Med 23 3 (1997) 524-528
103. Nichols N.R., Day J.R., Laping N.J., Johnson S.A., and Finch C.E. GFAP mRNA increases with age in rat and human brain. Neurobiol Aging 14 5 (1993) 421-429
104. Mattiace L.A., Davies P., and Dickson D.W. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol 136 5 (1990) 1101-1114
105. Sheng J.G., Mrak R.E., and Griffin W.S. Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol (Berl) 95 3 (1998) 229-234
106. Peters A., Josephson K., and Vincent S.L. Effects of aging on the neurologlial cells and pericytes within area 17 of the rhesus monkey cerebral cortex. Anat Rec 229 3 (1991) 384-398
107. Sheffield L.G., and Berman N.E. Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol Aging 19 1 (1998) 47-55
108. Rozovsky I., Finch C.E., and Morgan T.E. Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation. Neurobiol Aging 19 1 (1998) 97-103
109. Dickson D.W., Wertkin A., Kress Y., Ksiezak-Reding H., and Yen S.H. Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Lab Invest 63 1 (1990) 87-99
110. Nanamiya W., Takao T., Asaba K., De Souza E.B., and Hashimoto K. Effect of orchidectomy on the age-related modulation of IL-1beta and IL-1 receptors following lipopolysaccharide treatment in the mouse. neuroimmunomodulation 8 1 (2000) 13-19
111. Takao T., Nagano I., Tojo C., Takemura T., Makino S., Hashimoto K., et al. Age-related reciprocal modulation of interleukin-1 beta and interleukin-1 receptors in the mouse brain-endocrine-immune axis. Neuroimmunomodulation 3 4 (1996) 205-212
112. Terao A., Apte-Deshpande A., Dousman L., Morairty S., Eynon B.P., Kilduff T.S., et al. Immune response gene expression increases in the aging murine hippocampus. J Neuroimmunol 132 1-2 (2002) 99-112
113. Dinkel K., MacPherson A., and Sapolsky R.M. Novel glucocorticoid effects on acute inflammation in the CNS. J Neurochem 84 4 (2003) 705-716
114. Miller R.A. The aging immune system: primer and prospectus. Science 273 5271 (1996) 70-74
115. McGeer P.L., and McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21 2 (1995) 195-218
116. McGeer E.G., and McGeer P.L. Neurodegeneration and the immune system (1994), Saunders, Philadelphia, PA
117. Griffin W.S., Sheng J.G., Roberts G.W., and Mrak R.E. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 54 2 (1995) 276-281
118. Patterson P.H. Cytokines in Alzheimer's disease and multiple sclerosis. Curr Opin Neurobiol 5 5 (1995) 642-646
119. Strauss S., Bauer J., Ganter U., Ganter U., Jonas U., Berger M., and Volk B. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 66 2 (1992) 223-230
120. McEwen B.S., De Kloet E.R., and Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol Rev 66 4 (1986) 1121-1188
121. discussion 304-307. Sapolsky R.M. The physiological relevance of glucocorticoid endangerment of the hippocampus. Ann NY Acad Sci 746 (1994) 294-304
122. Besedovsky H.O., and del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17 1 (1996) 64-102
123. Haas H.S., and Schauenstein K. Neuroimmunomodulation via limbic structures-the neuroanatomy of psychoimmunology. Prog Neurobiol 51 2 (1997) 195-222
124. Murray C.A., Clements M.P., and Lynch M.A. Interleukin-1 induces lipid peroxidation and membrane changes in rat hippocampus: An age-related study. Gerontology 45 3 (1999) 136-142
125. Besedovsky H., del Rey A., Sorkin E., and Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233 4764 (1986) 652-654
126. Berkenbosch F., van Oers J., del Rey A., Tilders F., and Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238 4826 (1987) 524-526
127. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., and Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238 4826 (1987) 522-524